| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.052 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |